Literature DB >> 7790552

Peribiliary cysts in liver cirrhosis: US, CT, and MR findings.

N Terayama1, O Matsui, K Hoshiba, M Kadoya, J Yoshikawa, T Gabata, T Takashima, T Terada, Y Nakanuma, K Shinozaki.   

Abstract

OBJECTIVE: We report the imaging features of hepatic peribiliary cysts (PC) and the course of their development on CT.
MATERIALS AND METHODS: Both CT and US findings were correlated with histopathologic findings in two patients with PC at autopsy. Five patients with cysts around the portal vein on CT but without histologic correlation were also included in this study. In six patients the course of PC development was observed.
RESULTS: In the two autopsy cases cystic dilatation of the peribiliary glands was confirmed. The cases showed continuous small cysts along the portal veins reflecting the periportal collar seen on CT and the abnormal MR signal intensity of the periportal area. Ultrasound (US) showed round or tubular anechoic lesions around the large portal tracts mimicking dilatation of the bile ducts. Clustered cysts and echogenic dots or bands around PC were also seen. In three of six cases the PCs gradually enlarged and increased in number.
CONCLUSION: In patients with liver cirrhosis PCs can be demonstrated by CT, US, and MRI in the vicinity of the hepatic hilum. Peribiliary cysts enlarge gradually and must be differentiated from dilatation of bile ducts or edema of portal tracts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790552     DOI: 10.1097/00004728-199505000-00015

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  2 in total

1.  A case of peribiliary cysts accompanying bile duct carcinoma.

Authors:  Fumihiko Miura; Tadahiro Takada; Hodaka Amano; Masahiro Yoshida; Takahiro Isaka; Naoyuki Toyota; Keita Wada; Kenji Takagi; Kenichiro Kato
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Cystic tumors of the liver: a practical approach.

Authors:  Paolo Del Poggio; Marco Buonocore
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.